Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: The Relationship Between Diaphragm Muscle Thickness and Fibromyalgia
The completed clinical trial investigated the relationship between diaphragm muscle thickness and fibromyalgia, including associated anxiety…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: 'Nurture and Play' - a Pilot Study [NA]
Pilot clinical trial update for Nurture and Play investigating depression and anxiety; status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Supportive and Supportive-Expressive Treatment for Depression [NA]
The clinical trial evaluating supportive and supportive-expressive therapy for major depressive disorder has completed. Results have been po…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental application for aripiprazole (ARIPIPRAZOLE) under the ANDA pathway.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole from Alembic Pharmaceuticals, enabling the marketing of a generic version. This…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole, authorizing a generic ARIPIPRAZOLE product with the same in…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application from Apotex Corp. for aripiprazole (ANDA204094), authorizing changes to the generic product's approv…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for aripiprazole oral from Camber Pharmaceuticals, resulting in approval of this generic product's l…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Preventing Internalizing in Preadolescents Exposed to Chronic Stress [NA]
This clinical trial update reports a completed study by Penn State University focusing on preventing internalizing symptoms (anxiety and dep…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole from VistaPharm, LLC, for a generic aripiprazole product.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: rTMS for Military TBI-related Depression [NA]
A clinical trial is recruiting to evaluate repetitive transcranial magnetic stimulation for depressive symptoms in individuals with mild tra…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Cultural Adaptation of EMDR for Major Depressive Disorder and Compaire Its Online and Face-to-Face Testing [NA]
This clinical trial entry describes the cultural adaptation of EMDR therapy for major depressive disorder and compares online versus face-to…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic aripiprazole, authorizing a generic formulation of the antipsychotic.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application to authorize a new orally disintegrating tablet formulation of aripiprazole from Dr. Reddy's Laborat…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms [Phase 4]
Phase 4 clinical trial evaluating the efficacy of AXS-05 versus bupropion to prevent relapse of depressive symptoms is currently recruiting.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole (ARIPIPRAZOLE) under ANDA216351.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Detection Algorithm for Recurrence or Relapse of Depression Thanks to a Smartwach [NA]
This document updates a clinical trial evaluating a smartwatch-based algorithm to detect recurrence or relapse of depression; the study is c…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) [Phase 2]
Phase 2 XanaCIDD trial evaluating Xanamem in adults with major depressive disorder and cognitive impairment has completed.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Perioperative Depression, an Observational Cohort Study
An observational cohort study led by Karolinska Institutet examining perioperative depression in patients undergoing surgery with general an…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms [NA]
A completed clinical trial comparing Cognitive Behavioral Therapy to Ericksonian Hypnosis Therapy for depression and anxiety has finished; t…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Evaluation of an Asynchronous Remote Communities Approach to Behavioral Activation for Depressed Adolescents [NA]
This clinical trial entry describes a University of Washington study evaluating an asynchronous remote community approach to behavioral acti…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Improvement of Depression in Terminal Cancer Patients [NA]
A clinical trial from National Taiwan University Hospital aims to improve depression in terminal cancer patients and assess quality of life;…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression [Phase 2]
Phase 2 trial evaluating the efficacy and safety of psilocybin in adults with treatment-resistant major depressive disorder has completed, r…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy [NA]
A clinical trial evaluating pharmacist-guided pre-emptive pharmacogenetic testing to tailor antidepressant therapy for individuals with majo…